Publications

1. Allegretti JR, Kelly CR, Louie T, Fischer M, Hota S, Misra B, Van Hise NW, Yen E, Bullock JS, Silverman M, Davis I, McGill SK, Pardi DS, Orenstein R, Grinspan A, El-Nachef N, Feuerstadt P, Borody TJ, Khanna S, Budree S, Kassam Z. Safety and Tolerability of CP101, a Full-Spectrum, Oral Microbiome Therapeutic for the Prevention of Recurrent Clostridioides difficile Infection: A Phase 2 Randomized Controlled Trial. Gastroenterology. 2024 Oct 2 Epub 2024 Oct 02
   View PubMed
2. Cunningham CA, Grys TE, Downey FX, Saling CF, Orenstein R, Blair JE. Deep Sternal Wound Infection Caused by Rhizopus Species After Coronary Artery Bypass Graft. Open Forum Infect Dis. 2024 Jun; 11 (6):ofae302 Epub 2024 May 28
   View PubMed
3. Nagarakanti S, Grant L, Orenstein R. Managing Recurrent Vulvovaginal Candidiasis. J Womens Health (Larchmt). 2024 Feb; 33 (2):111-112 Epub 2023 Oct 04
   View PubMed
4. Speiser LJ, Wonnaparhown AM, Blair J, Shah A, Patel DR, McCullough AE, Nicolasora N, Khalsa AM, Orenstein R, Vikram HR, Huang V, Seville MT. A Case of Sustained Viral Shedding of Mpox With Ocular Involvement Resulting in Vision Loss. Open Forum Infect Dis. 2024 Jan; 11 (1):ofad632 Epub 2023 Dec 14
   View PubMed
5. Kasten MJ, Lahr BD, Parisapogu A, Yetmar ZA, O'Horo JC, Orenstein R, Moreno Franco P, Razonable RR, Vergidis P, Shah AS, Enzler MJ, Inwards DJ, Bauer PR. COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients. Sci Rep. 2023 Dec 1; 13 (1):21249 Epub 2023 Dec 01
   View PubMed
6. Orenstein R, Hecht G, Harvey A, Tillotson G, Khanna S. Two-year durability of REBYOTA (RBL), a live biotherapeutic for the prevention of recurrent Clostridioides difficile infections. Open Forum Infect Dis. 2023 Sep; 10 (9):ofad456 Epub 2023 Sept 08
   View PubMed
7. Johnson PW, Kunze KL, Senefeld JW, Sinclair JE, Isha S, Satashia PH, Bhakta S, Cowart JB, Bosch W, O'Horo J, Shah SZ, Wadei HM, Edwards MA, Pollock BD, Edwards AJ, Scheitel-Tulledge S, Clune CG, Hanson SN, Arndt R, Heyliger A, Kudrna C, Bierle DM, Buckmeier JR, Seville MTA, Orenstein R, Libertin C, Ganesh R, Franco PM, Razonable RR, Carter RE, Sanghavi DK, Speicher LL. Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11
   View PubMed
8. Dubberke ER, Orenstein R, Khanna S, Guthmueller B, Lee C. Final Results from a Phase 2b Randomized, Placebo-Controlled Clinical Trial of RBX2660: A Microbiota-Based Drug for the Prevention of Recurrent Clostridioides difficile Infection. Infect Dis Ther. 2023 Feb; 12 (2):703-709 Epub 2022 Dec 21
   View PubMed
9. Nagarakanti S, Orenstein R. Treating Clostridioides difficile: Could Microbiota-based Live Biotherapeutic Products Provide the Answer? Infect Drug Resist. 2023; 16:3137-3143 Epub 2023 May 20
   View PubMed
10. Lee C, Louie T, Bancke L, Guthmueller B, Harvey A, Feuerstadt P, Khanna S, Orenstein R, Dubberke ER. Safety of fecal microbiota, live-jslm (REBYOTA()) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials. Therap Adv Gastroenterol. 2023; 16:17562848231174277 Epub 2023 June 12
    View PubMed
11. Orenstein R. The Role of Microbiome-Based Therapeutics in Clostridioides difficile Infection: Durable, Long-Term Results of RBX2660. Infect Dis Ther. 2023 Jan; 12 (1):1-7 Epub 2022 Nov 07
    View PubMed
12. Haddad TC, Coffey JD, Deng Y, Glasgow AE, Christopherson LA, Sangaralingham LR, Bell SJ, Shah VP, Pritchett JC, Orenstein R, Speicher LL, Maniaci MJ, Ganesh R, Borah BJ. Impact of a High-Risk, Ambulatory COVID-19 Remote Patient Monitoring Program on Utilization, Cost, and Mortality. Mayo Clin Proc. 2022 Dec; 97(12):2215-2225. Epub 2022 Sep 06.
    View PubMed
13. Comba IY, Riestra Guiance I, Corsini Campioli C, Challener D, Sampathkumar P, Orenstein R, Gordon J, Bosch W, O'Horo JC. Clinical Characteristics and Outcomes of Patients With SARS-CoV-2 Reinfection. Mayo Clin Proc Innov Qual Outcomes. 2022 Aug; 6 (4):361-372 Epub 2022 May 30
    View PubMed
14. Speiser LJ, Kasule S, Hall CM, Sahl JW, Wagner DM, Saling C, Kole A, Meltzer AJ, Davila V, Orenstein R, Grys T, Graf E. A Case of Burkholderia pseudomallei Mycotic Aneurysm Linked to Exposure in the Caribbean via Whole-Genome Sequencing. Open Forum Infect Dis. 2022 May; 9 (5):ofac136 Epub 2022 Mar 21
    View PubMed
15. Orenstein R, Dubberke ER, Khanna S, Lee CH, Yoho D, Johnson S, Hecht G, DuPont HL, Gerding DN, Blount KF, Mische S, Harvey A. Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial. BMC Infect Dis. 2022 Mar 12; 22 (1):245
    View PubMed
16. Temesgen Z, Burger CD, Baker J, Polk C, Libertin CR, Kelley CF, Marconi VC, Orenstein R, Catterson VM, Aronstein WS, Durrant C, Chappell D, Ahmed O, Chappell G, Badley AD, LIVE-AIR Study Group. Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial. Lancet Respir Med. 2022 Mar; 10 (3):237-246 Epub 2021 Dec 01
    View PubMed
17. Jayasekera CR, Vikram HR, Rifat Z, Wagler J, Okubo K, Braaksma BR, Harbell JW, Jadlowiec CC, Katariya NN, Mathur AK, Moss A, Reddy KS, Singer A, Orenstein R, Saling CF, Seville MT, Mour GK, Vargas HE, Byrne TJ, Hewitt WR Jr, Aqel BA. Solid Organ Transplantation From SARS-CoV-2-infected Donors to Uninfected Recipients: A Single-center Experience. Transplant Direct. 2022 Feb; 8 (2):e1286 Epub 2022 Jan 13
    View PubMed
18. Cho J, Vazquez M, Orenstein R, Loftus EV Jr, DiBaise J, Pardi DS, Khanna S. Fecal microbial transplantation is effective for postcolectomy recurrent Clostridioides difficile infection Journal of Gastrointestinal Infections. 2022; 12(1):36-40.
    
19. Grant LM, Orenstein R. Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp. J Investig Med High Impact Case Rep. 2022 Jan-Dec; 10:23247096221123144.
    View PubMed
20. Ganesh R, Pawlowski CF, O'Horo JC, Arndt LL, Arndt RF, Bell SJ, Bierle DM, Borgen MD, Hanson SN, Heyliger A, Larsen JJ, Lenehan PJ, Orenstein R, Puranik A, Speicher LL, Tulledge-Scheitel SM, Venkatakrishnan AJ, Wilker CG, Badley AD, Razonable RR. Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19. J Clin Invest. 2021 Oct 1; 131 (19)
    View PubMed
21. Pritchett JC, Borah BJ, Desai AP, Xie Z, Saliba AN, Leventakos K, Coffey JD, Pearson KK, Speicher LL, Orenstein R, Virk A, Ganesh R, Paludo J, Halfdanarson TR, Haddad TC. Association of a Remote Patient Monitoring (RPM) Program With Reduced Hospitalizations in Cancer Patients With COVID-19. JCO Oncol Pract. 2021 Sep; 17 (9):e1293-e1302 Epub 2021 June 04
    View PubMed
22. Coffey JD, Christopherson LA, Glasgow AE, Pearson KK, Brown JK, Gathje SR, Sangaralingham LR, Carmona Porquera EM, Virk A, Orenstein R, Speicher LL, Bierle DM, Ganesh R, Cox DL, Blegen RN, Haddad TC. Implementation of a multisite, interdisciplinary remote patient monitoring program for ambulatory management of patients with COVID-19. NPJ Digit Med. 2021 Aug 13; 4 (1):123
    View PubMed
23. Blair JE, Gotimukul A, Wang F, Mina SA, Bartels HC, Burns MW, Kole AE, Vikram HR, Gea-Banacloche JC, Seville MT, Petty SAB, Vikram A, Orenstein R. Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illness. Medicine (Baltimore). 2021 Jun 18; 100 (24):e26371
    View PubMed
24. Razonable RR, Aloia NCE, Anderson RJ, Anil G, Arndt LL, Arndt RF, Ausman SE, Bell SJ, Bierle DM, Billings ML, Bishop RK, Cramer CH, Culbertson TL, Dababneh AS, Derr AN, Epps K, Flaker SM, Ganesh R, Gilmer MA, Urena EG, Gulden CR, Haack TL, Hanson SN, Herzog JR, Heyliger A, Hokanson LD, Hopkins LH, Horecki RJ, Krishna BH, Huskins WC, Jackson TA, Johnson RR, Jorgenson B, Kudrna C, Kennedy BD, Klingsporn MK, Kottke B, Larsen JJ, Lessard SR, Lutwick LI, Malone EJ 3rd, Matoush JA, Micallef IN, Moehnke DE, Mohamed M, Ness CN, Olson SM, Orenstein R, Palraj R, Patel J, Paulson DJ, Phelan D, Peinovich MT, Ramsey WL, Rau-Kane TJ, Reid KI, Reinschmidt KJ, Seville MT, Skold EC, Smith JM, Speicher LL, Spielman LA, Springer DJ, Sweeten PW, Tempelis JM, Tulledge-Scheitel S, Vergidis P, Whipple DC, Wilker CG, Destro Borgen MJ. A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model. Mayo Clin Proc. 2021 May; 96 (5):1250-1261 Epub 2021 Mar 09
    View PubMed
25. O'Horo JC, Cerhan JR, Cahn EJ, Bauer PR, Temesgen Z, Ebbert J, Abril A, Abu Saleh OM, Assi M, Berbari EF, Bierle DM, Bosch W, Burger CD, Cano Cevallos EJ, Clements CM, Carmona Porquera EM, Castillo Almeida NE, Challener DW, Chesdachai S, Comba IY, Corsini Campioli CG, Crane SJ, Dababneh AS, Enzler MJ, Fadel HJ, Ganesh R, De Moraes AG, Go JR, Gordon JE, Gurram PR, Guru PK, Halverson EL, Harrison MF, Heaton HA, Hurt R, Kasten MJ, Lee AS, Levy ER, Libertin CR, Mallea JM, Marshall WF 3rd, Matcha G, Meehan AM, Franco PM, Morice WG 2nd, O'Brien JJ, Oeckler R, Ommen S, Oravec CP, Orenstein R, Ough NJ, Palraj R, Patel BM, Pureza VS, Pickering B, Phelan DM, Razonable RR, Rizza S, Sampathkumar P, Sanghavi DK, Sen A, Siegel JL, Singbartl K, Shah AS, Shweta F, Speicher LL, Suh G, Tabaja H Jr, Tande A, Ting HH, Tontz RC 3rd, Vaillant JJ, Vergidis P, Warsame MY, Yetmar ZA, Zomok CCD, Williams AW, Badley AD. Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research. Mayo Clin Proc. 2021 Mar; 96 (3):601-618 Epub 2020 Dec 26
    View PubMed
26. Tariq R, Laguio-Vila M, Tahir MW, Orenstein R, Pardi DS, Khanna S. Efficacy of oral vancomycin prophylaxis for prevention of Clostridioides difficile infection: a systematic review and meta-analysis. Therap Adv Gastroenterol. 2021; 14:1756284821994046 Epub 2021 Feb 23
    View PubMed
27. Temesgen Z, Assi M, Shweta FNU, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Palraj R, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C, Kenderian SS, Badley AD. GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study. Mayo Clin Proc. 2020 Nov; 95 (11):2382-2394 Epub 2020 Sept 03
    View PubMed
28. Burger CD, Mikhail AE, Orenstein R, Ebbert JO, Vergidis P, Badley AD. Research Response to SARS-CoV-2/COVID-19. Mayo Clin Proc. 2020 Sep; 95 (9S):S52-S55 Epub 2020 July 07
    View PubMed
29. Tariq R, Disbrow MB, Dibaise JK, Orenstein R, Saha S, Solanky D, Loftus EV, Pardi DS, Khanna S. Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020 Aug 20; 26 (9):1415-1420
    View PubMed
30. Temesgen Z, Assi M, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Varatharaj Palraj BR, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C, Kenderian SS, Badley A. First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia. medRxiv 2020 Jun 14 Epub 2020 June 14
    View PubMed
31. Blech B, Christiansen M, Asbury K, Orenstein R, Ross M, Grill M. Polyneuritis cranialis after acute tularemia infection: A case study. Muscle Nerve. 2020 Jan; 61 (1):E1-E2 Epub 2019 Nov 07
    View PubMed
32. Orenstein R. The Art and Science of Osteopathic Medicine. J Am Osteopath Assoc. 2019 May 1; 119 (5):281
    View PubMed
33. Orenstein R, Patron RL, Seville MT. Why Does Clostridium difficile Infection Recur? J Am Osteopath Assoc. 2019 May 1; 119 (5):322-326
    View PubMed
34. Valencia-Sanchez C, Steenerson KK, Kelemen K, Orenstein R, Kusne S, Grill MF. Post-transplant primary central nervous system lymphoma after Epstein-Barr virus cerebellitis. J Neurovirol. 2019 Apr; 25 (2):280-283 Epub 2019 Jan 03
    View PubMed
35. Orenstein R, Patron RL. Clostridioides difficile therapeutics: guidelines and beyond. Ther Adv Infect Dis. 2019 Jan-Dec; 6:2049936119868548 Epub 2019 Aug 13
    View PubMed
36. Dubberke ER, Lee CH, Orenstein R, Khanna S, Hecht G, Gerding DN. Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection. Clin Infect Dis. 2018 Sep 28; 67 (8):1198-1204
    View PubMed
37. Tariq R, Cho J, Kapoor S, Orenstein R, Singh S, Pardi DS, Khanna S. Low Risk of Primary Clostridium difficile Infection With Tetracyclines: A Systematic Review and Metaanalysis. Clin Infect Dis. 2018 Feb 01; 66(4):514-522.
    View PubMed
38. Orenstein R, King K, Patron RL, DiBaise JK, Etzioni D. Mini-Fecal Microbiota Transplantation for Treatment of Clostridium difficile Proctitis Following Total Colectomy. Clin Infect Dis. 2018 Jan 6; 66 (2):299-300
    View PubMed
39. Patron RL, Hartmann CA, Allen S, Griesbach CL, Kosiorek HE, DiBaise JK, Orenstein R. Vancomycin Taper and Risk of Failure of Fecal Microbiota Transplantation in Patients With Recurrent Clostridium difficile Infection. Clin Infect Dis. 2017 Oct 1; 65 (7):1214-1217
    View PubMed
40. Hartmann CA, Vikram HR, Seville MT, Orenstein R, Kusne S, Blair JE, Grys TE, Patron RL. Neuroinvasive St. Louis Encephalitis Virus Infection in Solid Organ Transplant Recipients. Am J Transplant. 2017 Aug; 17 (8):2200-2206 Epub 2017 May 27
    View PubMed
41. Orenstein R. History of Osteopathic Medicine: Still Relevant? J Am Osteopath Assoc. 2017 Mar 01; 117: (3)148.
    View PubMed
42. Fitterer C, Berg Z, Halfdanarson TR, Vikram HR, Kusne S, Orenstein R, Seville MT, Blair JE. Coccidioidomycosis in Patients with Selected Solid Organ Cancers: A Case Series and Review of Medical Literature. Mycopathologia. 2016 Dec; 181 (11-12):787-798 Epub 2016 Aug 04
    View PubMed
43. Leekha S, Lahr BD, Thompson RL, Sampathkumar P, Duncan AA, Orenstein R. Preoperative risk prediction of surgical site infection requiring hospitalization or reoperation in patients undergoing vascular surgery. J Vasc Surg. 2016 Jul; 64 (1):177-84 Epub 2016 Feb 27
    View PubMed
44. Scotch AH, Hoss E, Orenstein R, Budavari AI. Disseminated Varicella-Zoster Virus After Vaccination in an Immunocompetent Patient. J Am Osteopath Assoc. 2016 Jun 1; 116: (6)402-5.
    View PubMed
45. Orenstein R. ENGAGE Initiative: Showcasing Osteopathic Scholarly Activity. J Am Osteopath Assoc. 2016 May 1; 116: (5)276-7.
    View PubMed
46. Orenstein R, Dubberke E, Hardi R, Ray A, Mullane K, Pardi DS, Ramesh MS, PUNCH CD Investigators. Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study. Clin Infect Dis. 2016 Mar 1; 62 (5):596-602 Epub 2015 Nov 12
    View PubMed
47. Seto CT, Jeraldo P, Orenstein R, Chia N, DiBaise JK. Erratum to: Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility. Microbiome. 2016 Feb 22; 4:10
    View PubMed
48. Campbell M, Kusne S, Renfree KJ, Vikram HR, Smilack JD, Seville MT, Orenstein R, Blair JE. Coccidioidal Tenosynovitis of the Hand and Wrist: Report of 9 Cases and Review of the Literature. Clin Infect Dis. 2015 Nov 15; 61: (10)1514-20.
    View PubMed
49. Blair JE, Chang YH, Cheng MR, Vaszar LT, Vikram HR, Orenstein R, Kusne S, Ho S, Seville MT, Parish JM. Characteristics of patients with mild to moderate primary pulmonary coccidioidomycosis. Emerg Infect Dis. 2014 Jun; 20(6):983-90.
    View PubMed
50. Seto CT, Jeraldo P, Orenstein R, Chia N, DiBaise JK. Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility. Microbiome. 2014; 2:42 Epub 2014 Nov 25
    View PubMed
51. Orenstein R, Griesbach CL, DiBaise JK. Moving fecal microbiota transplantation into the mainstream. Nutr Clin Pract. 2013 Oct; 28 (5):589-98 Epub 2013 Aug 26
    View PubMed
52. Patel NC, Griesbach CL, DiBaise JK, Orenstein R. Fecal microbiota transplant for recurrent Clostridium difficile infection: Mayo Clinic in Arizona experience. Mayo Clin Proc. 2013 Aug; 88 (8):799-805
    View PubMed
53. Azadeh N, Chang YH, Kusne S, Vikram HR, Seville MT, Orenstein R, Blair JE. The impact of early and brief corticosteroids on the clinical course of primary pulmonary coccidioidomycosis. J Infect. 2013 Aug; 67(2):148-55. Epub 2013 Apr 6
    View PubMed
54. Leekha S, Aronhalt KC, Sloan LM, Patel R, Orenstein R. Asymptomatic Clostridium difficile colonization in a tertiary care hospital: admission prevalence and risk factors. Am J Infect Control. 2013 May; 41 (5):390-3
    View PubMed
55. Virk A, Mandrekar J, Berbari EF, Boyce TG, Fischer PR, Kasten MJ, Orenstein R, Rosenblatt JE, Sampathkumar P, Sia I, Springer D, Witzig TE. A randomized, double blind, placebo-controlled trial of an oral synbiotic (AKSB) for prevention of travelers' diarrhea. J Travel Med. 2013 Mar-Apr; 20 (2):88-94 Epub 2013 Jan 25
    View PubMed
56. Aronhalt K, McManus J, Orenstein R, Faller R, Link M. Patient and Environmental Service Employee Satisfaction of Using Germicidal Bleach Wipes for Patient Room Cleaning. Journal for Healthcare Quality. 2012.
    
57. Gallegos-Orozco JF, Paskvan-Gawryletz CD, Gurudu SR, Orenstein R. Successful colonoscopic fecal transplant for severe acute Clostridium difficile pseudomembranous colitis. Rev Gastroenterol Mex. 2012 Jan-Mar; 77: (1)40-2.
    View PubMed
58. Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, St Sauver JL, Harmsen WS, Zinsmeister AR. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012 Jan; 107 (1):89-95 Epub 2011 Nov 22
    View PubMed
59. Orenstein R, Aronhalt KC, McManus JE Jr, Fedraw LA. A targeted strategy to wipe out Clostridium difficile. Infect Control Hosp Epidemiol. 2011 Nov; 32 (11):1137-9 Epub 2011 Oct 06
    View PubMed
60. Olson TC, Bongartz T, Crowson CS, Roberts GD, Orenstein R, Matteson EL. Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009. BMC Infect Dis. 2011 May 23; 11:145
    View PubMed
61. Kamal A, Orenstein R. Disseminated sporotrichosis. J Hosp Med. 2010 Mar; 5(3):E29-30.
    View PubMed
62. Drage LA, Ecker PM, Orenstein R, Phillips PK, Edson RS. An outbreak of Mycobacterium chelonae infections in tattoos. J Am Acad Dermatol. 2010 Mar; 62(3):501-6. Epub 2009 Sep 06.
    View PubMed
63. Orenstein R, Litin SC. Clinical pearls in infectious diseases. Mayo Clin Proc. 2010 Feb; 85 (2):172-5
    View PubMed
64. Lachance DH, Lennon VA, Pittock SJ, Tracy JA, Krecke KN, Amrami KK, Poeschla EM, Orenstein R, Scheithauer BW, Sejvar JJ, Holzbauer S, Devries AS, Dyck PJ. An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study. Lancet Neurol. 2010 Jan; 9 (1):55-66 Epub 2009 Nov 27
    View PubMed
65. Verdoorn BP, Orenstein R, Rosenblatt JE, Sloan LM, Schleck CD, Harmsen WS, Nyre LM, Patel R. High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severity. Diagn Microbiol Infect Dis. 2010 Jan; 66 (1):24-8 Epub 2009 Sept 23
    View PubMed
66. Verdoorn BP, Orenstein R, Wilson JW, Estes LL, Wendt RF, Schleck CD, Harmsen WS, Nyre LM, Patel R. Effect of telephoned notification of positive Clostridium difficile test results on the time to the ordering of antimicrobial therapy. Infect Control Hosp Epidemiol. 2008 Jul; 29 (7):658-60
    View PubMed
67. Toruner M, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, Colombel JF, Egan LJ. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology. 2008 Apr; 134 (4):929-36 Epub 2008 Jan 11
    View PubMed
68. Mauermann ML, Klein CJ, Orenstein R, Dyck PJ. Disseminated sporotrichosis presenting with granulomatous inflammatory multiple mononeuropathies. Muscle Nerve. 2007 Dec; 36(6):866-72.
    View PubMed
69. Orenstein R, Matteson EL. Opportunistic infections associated with TNF-alpha treatment. Future Rheumatology. 2007; 2(6):567-76.
    
70. Claassen DO, Batsis JA, Orenstein R. Proteus mirabilis: a rare cause of infectious endocarditis. Scand J Infect Dis. 2007; 39(4):373-5.
    View PubMed
71. Uslan DZ, Jacobson KM, Kumar N, Berbari EF, Orenstein R. A woman with fever and rash after African safari. Clin Infect Dis. 2006 Sep 1; 43(5):609, 661-2.
    View PubMed
72. Kumar N, Orenstein R, Uslan DZ, Berbari EF, Klein CJ, Windebank AJ. Melarsoprol-associated multifocal inflammatory CNS illness in African trypanosomiasis. Neurology. 2006 Apr 11; 66(7):1120-1. Epub 2006 Mar 15.
    View PubMed
73. Eid AJ, Orenstein R. Metabolic and morphologic complications of HIV infection. J Med Liban. 2006 Apr-Jun; 54(2):97-105.
    View PubMed
74. Orenstein R, Matteson EL. TNF inhibitors and infections... tumor necrosis factor. Infections in Medicine. 2006 Mar; 23(3):99-102, 109-14.
    
75. Orenstein R. Infections related to TNF-alpha inhibitors. Expert Reviews in Dermatology. 2006; 1(5):737-749.
    
76. Orenstein R. Andrew Taylor Still and the Mayo brothers: convergence and collaboration in 21st-century osteopathic practice. J Am Osteopath Assoc. 2005 May; 105(5):251-4.
    View PubMed
77. Orenstein R. Travel in patients receiving TNF-alpha inhibitors. Travel Medicine & Infectious Disease. 2005; 3(2):105-9.
    
78. Prabhu RM, Bonnell M, Currier BL, Orenstein R. Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole. Clin Infect Dis. 2004 Oct 1; 39(7):e74-7. Epub 2004 Sep 10.
    View PubMed
79. Orenstein R, Tsogas N. Looking beyond highly active antiretroviral therapy: drug-related hepatotoxicity in patients with human immunodeficiency virus infection. Pharmacotherapy. 2002 Nov; 22 (11):1468-78
    View PubMed
80. Orenstein R. Presenting syndromes of human immunodeficiency virus. Mayo Clin Proc. 2002 Oct; 77 (10):1093-102; quiz 1102
    View PubMed
81. Orenstein R. Hepatitis C - HIV co-infection in women. Symposia on GI disorders in women. J Am Osteo Assoc. 2001 Dec; 101(12):S1-7.
    
82. Orenstein R, Tsogas N. Hepatitis C virus and human immunodeficiency virus co-infection in women. J Am Osteopath Assoc. 2001 Dec; 101(12 Suppl Pt 2):S1-6.
    View PubMed
83. LeGall-Salmon E, Orenstein R. Doxycycline for switch therapy in community acquired pneumonia. Infect Dis Clin Pract. 1999 Dec.
    
84. Link K, Orenstein R. Bacterial complications of strongyloidiasis: Streptococcus bovis meningitis. South Med J. 1999 Jul; 92(7):728-31.
    View PubMed
85. Orenstein R, Wong ES. Urinary tract infections in adults. Am Fam Physician. 1999 Mar 1; 59(5):1225-34, 1237.
    View PubMed
86. Orenstein R. The benefits and limitations of needle protectors and needleless intravenous systems. Journal of Intravenous Nursing. 1999; 22:122-8.
    View PubMed
87. Orenstein R, LeGall-Salmon E. HIV-treatment associated hepatitis. AIDS Reader. 1999; 9:339-47.
    View PubMed
88. Foxx-Orenstein AE, Orenstein R. Antibiotics and pancreatitis. Gastroenterologist. 1997; 5:157-64.
    View PubMed
89. Orenstein R, Karabaic M, Reynolds L, Lamb A, Markowitz SM, Wong ES. Are protective devices effective at preventing needlestick injuries among healthcare workers? Am J Infect Control. 1995; 23:322-30.
    View PubMed
90. Orenstein R. Candidemia following candiduria: not so benign and not so delayed. Clin Infect Dis. 1994; 19:207-8.
    View PubMed
91. Orenstein R, Dahlman M, Bross JE. Risk factors for urinary lithotripsy - associated sepsis. Infect Control Hosp Epidemiol. 1993; 14:469-72.
    View PubMed